Methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients. Results from the MOTION trial

PURPOSE: Constipation can be a significant problem in critically unwell patients, associated with detrimental outcomes. Opioids are thought to contribute to the mechanism of bowel dysfunction. We tested if methylnaltrexone, a pure peripheral mu-opioid receptor antagonist, could reverse opioid-induce...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Intensive Care Med
Päätekijät: Patel, Parind B., Brett, Stephen J., O’Callaghan, David, Anjum, Aisha, Cross, Mary, Warwick, Jane, Gordon, Anthony C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2020
Aiheet:
Original
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7223905/
https://ncbi.nlm.nih.gov/pubmed/32016532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00134-019-05913-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia